---
document_datetime: 2023-09-21 17:58:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/foscan-epar-all-authorised-presentations_en.pdf
document_name: foscan-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8584457
conversion_datetime: 2025-12-20 14:34:26.892808
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical form    | Route of administration   | Packaging          | Content   | Package size   |
|-----------------|-----------------|------------|------------------------|---------------------------|--------------------|-----------|----------------|
| EU/1/01/197/003 | Foscan          | 1 mg/ml    | Solution for injection | Intravenous use           | Vial (amber glass) | 1 ml      | 1 vial         |
| EU/1/01/197/004 | Foscan          | 1 mg/ml    | Solution for injection | Intravenous use           | Vial (amber glass) | 3 ml      | 1 vial         |
| EU/1/01/197/005 | Foscan          | 1 mg/ml    | Solution for injection | Intravenous use           | Vial (amber glass) | 6 ml      | 1 vial         |